Status:
COMPLETED
High-Flow Nasal Cannula Versus Conventional Oxygen Therapy After Extubation in Liver Transplantation
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Gas Exchange
Eligibility:
All Genders
18+ years
Brief Summary
Humidified oxygen therapy via high-flow nasal cannula (HFNC) is a recently available technique delivering heated and humidified high flow oxygen through simple nasal prongs. In immunocompetent patient...
Detailed Description
Humidified oxygen therapy via high-flow nasal cannula (HFNC) is a recently available technique delivering heated and humidified high flow oxygen through simple nasal prongs. HFNC provides flows up to ...
Eligibility Criteria
Inclusion
- Liver transplantation surgery
- Presence of criteria to start a weaning trial
Exclusion
- Patient \< 18 years
- Need of cardiovascular resuscitation
- Glasgow Coma Score ≤ 8
- Hemodynamic instability
Key Trial Info
Start Date :
June 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03441854
Start Date
June 1 2018
End Date
December 31 2018
Last Update
October 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Gemelli
Rome, Italy, 00168